Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis

References

• AlvarJVelezIDBernCWHO Leishmaniasis Control TeamLeishmaniasis worldwide and global estimates of its incidencePLoS One201275e3567122693548
   PubMed Web of Science ®Google Scholar
• HerwaldtBLLeishmaniasisLancet199935491851191119910513726
   PubMed Web of Science ®Google Scholar
• CraggGMNewmanDJNatural products: a continuing source of novel drug leadsBiochim Biophys Acta2013183063670369523428572
   PubMed Web of Science ®Google Scholar
• SinghNMishraBBBajpaiSSinghRKTiwariVKNatural product based leads to fight against leishmaniasisBioorg Med Chem2014221184524355247
   PubMed Web of Science ®Google Scholar
• da Costa-SilvaTAGreccoSSde SousaFSImmunomodulatory and antileishmanial activity of phenylpropanoid dimers isolated from Nectandra leucanthaJ Nat Prod201578465365725835647
   PubMed Web of Science ®Google Scholar
• AnnangFPerez-MorenoGGarcia-HernandezRHigh-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas diseaseJ Biomol Screen2015201829125332350
   PubMed Web of Science ®Google Scholar
• SenRGangulySSahaPChatterjeeMEfficacy of artemisinin in experimental visceral leishmaniasisInt J Antimicrob Agents2010361434920403680
   PubMed Web of Science ®Google Scholar
• ChenYLinXParkHGreeverRStudy of artemisinin nanocapsules as anticancer drug delivery systemsNanomedicine20095331632219523432
   PubMed Web of Science ®Google Scholar
• WantMYIslamuddinMChouhanGDasguptaAKChattopadhyayAPAfrinFA new approach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studiesJ Colloid Interface Sci201443225826925086720
   PubMed Web of Science ®Google Scholar
• LetchmananKShenSCNgWKTanRBEnhanced dissolution and stability of artemisinin by nano-confinement in ordered mesoporous SBA-15 particlesJ Microencapsul201532439040026004369
   PubMed Web of Science ®Google Scholar
• FaezizadehZGharibAGodarzeeMIn-vitro and in-vivo evaluation of silymarin nanoliposomes against isolated methicillin-resistant Staphylococcus aureusIran J Pharm Res201514262763325901172
   PubMed Web of Science ®Google Scholar
• GasparMMCaladoSPereiraJTargeted delivery of paromomycin in murine infectious diseases through association to nano lipid systemsNanomedicine20151171851186026169150
   PubMedGoogle Scholar
• CarvalheiroMEstevesMASantos-MateusDHemisynthetic trifluralin analogues incorporated in liposomes for the treatment of leishmanial infectionsEur J Pharm Biopharm20159334635225936854
   PubMedGoogle Scholar
• AlvingCRSteckEAChapmanWLJrTherapy of leishmaniasis: superior efficacies of liposome-encapsulated drugsProc Natl Acad Sci U S A197875629592963208079
   PubMed Web of Science ®Google Scholar
• AlvingCRSteckEAHansonWLLoizeauxPSChapmanWLJrWaitsVBImproved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drugLife Sci1978221210211026642712
   PubMed Web of Science ®Google Scholar
• BlackCDWatsonGJWardRJThe use of Pentostam liposomes in the chemotherapy of experimental leishmaniasisTrans R Soc Trop Med Hyg1977716550552204085
   PubMed Web of Science ®Google Scholar
• NewRRChanceMLThomasSCPetersWAntileishmanial activity of antimonials entrapped in liposomesNature197827256485556203863
   PubMed Web of Science ®Google Scholar
• HunterCADolanTFCoombsGHBaillieAJVesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasisJ Pharm Pharmacol19884031611652899143
   PubMed Web of Science ®Google Scholar
• RoychoudhuryJSinhaRAliNTherapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c micePLoS One201163e1737621423750
   PubMed Web of Science ®Google Scholar
• GharibAFaezizadehZMesbah-NaminSAIn vitro and in vivo antibacterial activities of cyanidinum chloride-loaded liposomes against a resistant strain of Pseudomonas aeruginosaPlanta Med2013791151923203413
   PubMedGoogle Scholar
• BalasegaramMRitmeijerKLimaMALiposomal amphotericin B as a treatment for human leishmaniasisExpert Opin Emerg Drugs201217449351023167833
   PubMed Web of Science ®Google Scholar
• AllenTMCullisPRLiposomal drug delivery systems: from concept to clinical applicationsAdv Drug Deliv Rev2013651364823036225
   PubMed Web of Science ®Google Scholar
• AfrinFAliNAdjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomesInfect Immun1997656237123779169776
   PubMed Web of Science ®Google Scholar
• MunasurAPPillayVChettyDJGovenderTStatistical optimisation of the mucoadhesivity and characterisation of multipolymeric propranolol matrices for buccal therapyInternational journal of pharmaceutics20063231–2435116863686
   PubMedGoogle Scholar
• YangCRZhaoXLHuHYPreparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers. Chem Pharm BullMay2010585656661
   Google Scholar
• IsacchiBArrigucciSla MarcaGConventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in miceJ Liposome Res201121323724421158702
   PubMed Web of Science ®Google Scholar
• BharatiASabatSCA spectrophotometric assay for quantification of artemisininTalanta20108231033103720678664
   PubMedGoogle Scholar
• NaharMJainNKPreparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticlesPharm Res200926122588259819842021
   PubMed Web of Science ®Google Scholar
• ManandharKDYadavTPPrajapatiVKAntileishmanial activity of nano-amphotericin B deoxycholateJ Antimicrob Chemother200862237638018453526
   PubMed Web of Science ®Google Scholar
• DingAHNathanCFStuehrDJRelease of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent productionJ Immunol19881417240724123139757
   PubMed Web of Science ®Google Scholar
• WantMYIslamuddinMChouhanGTherapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasisColloids Surf B Biointerfaces201513021522125936561
   PubMed Web of Science ®Google Scholar
• FulcherDWongSCarboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratoryImmunol Cell Biol199977655956410571678
   PubMed Web of Science ®Google Scholar
• McHughTMFlow microsphere immunoassay for the quantitative and simultaneous detection of multiple soluble analytesMethods Cell Biol199442pt B5755957877510
   PubMedGoogle Scholar
• BanduwardeneRMullenABCarterKCImmune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulationsInt J Immunopharmacol19971941952039373770
   PubMedGoogle Scholar
• ClogstonJDPatriAKZeta potential measurementMethods Mol Biol2011697637021116954
   PubMedGoogle Scholar
• RudraADeepaRMGhoshMKGhoshSMukherjeeBDoxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in ratsInt J Nanomedicine2010581182321042545
   PubMed Web of Science ®Google Scholar
• LinJYuYShigdarSEnhanced antitumor efficacy and reduced systemic toxicity of sulfatide-containing nanoliposomal doxorubicin in a xenograft model of colorectal cancerPLoS One2012711e4927723145140
   PubMed Web of Science ®Google Scholar
• DrummondDCNobleCOGuoZHongKParkJWKirpotinDBDevelopment of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategyCancer Res20066663271327716540680
   PubMed Web of Science ®Google Scholar
• RochaPNMacedoMNKobayashiCDRole of urine neutrophil gelatinase-associated lipocalin in the early diagnosis of amphotericin B-induced acute kidney injuryAntimicrob Agents Chemother201559116913692126303800
   PubMed Web of Science ®Google Scholar
• GweeACranswickNConnellTGCurtisNMinimizing nephrotoxicity using continuous infusion of deoxycholate amphotericin BPediatr Infect Dis J201433101098
   PubMedGoogle Scholar
• VonarbourgAPassiraniCSaulnierPSimardPLerouxJCBenoitJPEvaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptakeJ Biomed Mater Res A200678362062816779767
   PubMed Web of Science ®Google Scholar
• ProudfootLNikolaevAVFengGJRegulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophagesProc Natl Acad Sci U S A1996932010984109898855295
   PubMedGoogle Scholar
• ChenYLuYChenJEnhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile saltInt J Pharm20093761–215316019394416
   PubMed Web of Science ®Google Scholar
• GuanPLuYQiJEnhanced oral bioavailability of cyclosporine A by liposomes containing a bile saltInt J Nanomedicine2011696597421720508
   PubMed Web of Science ®Google Scholar
• BorboremaSESchwendenerRAOssoJAJrde AndradeHFJrdo NascimentoNUptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophagesInt J Antimicrob Agents201138434134721783345
   PubMed Web of Science ®Google Scholar
• JoshiJKaurSTo investigate the therapeutic potential of immunochemotherapy with cisplatin +78 kDa + MPL-A against Leishmania donovani in BALB/c miceParasite Immunol201436131223964700
   PubMed Web of Science ®Google Scholar
• JoshiJMallaNKaurSA comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental studyParasitol Int201463461262024747611
   PubMedGoogle Scholar
• CarvalhoEMBacellarOBrownellCRegisTCoffmanRLReedSGRestoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasisJ Immunol199415212594959568207220
   PubMed Web of Science ®Google Scholar
• TaylorAPMurrayHWIntracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted miceJ Exp Med19971857123112399104810
   PubMedGoogle Scholar
• MirallesGDStoeckleMYMcDermottDFFinkelmanFDMurrayHWTh1 and Th2 cell-associated cytokines in experimental visceral leishmaniasisInfect Immun1994623105810638112840
   PubMedGoogle Scholar